|
1
|
Martins F, Couturier DL, de Santiago I, Vias M, Sanders D, Piskorz A, Hall J, Jimenez-Linan M, Hosking K, Crawford R, Brenton J. Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz413.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
2
|
Brenton J, Banwell B, Bergqvist C, Lehner-Gulotta D, Leytham E, Gampper L, Goldman M, Coleman R. Application of a Modified Ketogenic Diet in Relapsing-Remitting Multiple Sclerosis Subjects. J Acad Nutr Diet 2019. [DOI: 10.1016/j.jand.2019.06.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
|
3
|
Davis B, Tian K, Pahlitzsch M, Brenton J, Ravindran N, Butt G, Malaguarnera G, Normando E, Guo L, Cordeiro M. Corrigendum to “Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension” [Mitochondrion 36 (2017) 114–123]. Mitochondrion 2019; 47:330. [PMID: 31108262 PMCID: PMC6854459 DOI: 10.1016/j.mito.2019.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
|
4
|
Goranova T, Macintyre G, De Silva D, Ennis D, McNeish I, Brenton J. PO-489 TP53 mutations and focal genomic amplifications for ctDNA detection in high-grade serous ovarian carcinoma. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
|
5
|
Moore E, Chandrananda D, Piskorz A, Mouliere F, Goranova T, Addley H, Crawford R, Parkinson C, Rosenfeld N, Brenton J. PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
|
6
|
Banwell B, Brenton J. Autoimmune Diseases of the Central Nervous System in Childhood. J Pediatr Neurol 2018. [DOI: 10.1055/s-0037-1606610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Brenda Banwell
- Division of Child Neurology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
| | - J. Brenton
- Division of Pediatric Neurology, Department of Neurology, University of Virginia, Charlottesville, Virginia, United States
| |
Collapse
|
|
7
|
Clamp A, McNeish I, Dean A, Gallardo D, Weon-Kim J, O'Donnell D, Hook J, Coyle C, Blagden S, Brenton J, Naik R, Perren T, Sundar S, Cook A, James E, Swart A, Stenning S, Kaplan R, Ledermann J. ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx440.039] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
8
|
Oaknin A, Oza A, Tinker A, Ray-Coquard I, Coleman R, O’Malley D, Shapira-Frommer R, Leary A, Chen L, Provencher D, Ma L, Brenton J, Balmaña J, Giordano H, Maloney L, Goble S, Rolfe L, McNeish I, Swisher E, Kristeleit R. Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC). Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30395-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
|
9
|
Affiliation(s)
- B M Davis
- Glaucoma and Retinal Neurodegeneration Research, Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
| | - L Guo
- Glaucoma and Retinal Neurodegeneration Research, Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
| | - J Brenton
- Glaucoma and Retinal Neurodegeneration Research, Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
| | - L Langley
- Glaucoma and Retinal Neurodegeneration Research, Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
| | - E M Normando
- Western Eye Hospital, Imperial College Healthcare Trust, London, UK
| | - M F Cordeiro
- Glaucoma and Retinal Neurodegeneration Research, Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
- Western Eye Hospital, Imperial College Healthcare Trust, London, UK
| |
Collapse
|
|
10
|
Kristeleit R, Swisher E, Oza A, Coleman R, Scott C, Konecny G, Tinker A, O'Malley D, Brenton J, Bell-McGuinn K, Oaknin A, Leary A, Lin K, Raponi M, Giordano H, Maloney L, Goble S, Yelensky R, McNeish I. 2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(15)30050-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
|
11
|
Swisher E, Brenton J, Kaufmann S, Oza A, Coleman R, O'Malley D, Konecny G, Ma L, Harrell M, Visscher D, Hendrickson A, Lin K, Raponi M, Mann E, Giordano H, Maloney L, Rolfe L, McNeish I. 215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70341-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
|
12
|
McNeish I, Coleman R, Oza A, Konecny G, O'Malley D, Kichenadasse G, Scott C, Oaknin A, Floquet A, Park D, Brenton J, Lin K, Shetty S, Giordano H, Raponi M, Rolfe L, Swisher E. Preliminary Results of Ariel2, a Phase 2 Open-Label Study to Identify Ovarian Cancer Patients Likely to Respond to Rucaparib. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu338.9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
13
|
Gounaris I, Brenton J. Arid1A Role in Cell Cycle Regulation and Proliferation in Mouse and Human Gynaecological Tissues Reveals Potential Therapeutic Targets. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu325.1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
14
|
Zahra M, Sala E, Lomas D, Crawford R, Brenton J, Arends M, Tan L. The Predictive Role of Functional Imaging in Cervix Cancer. Clin Oncol (R Coll Radiol) 2007. [DOI: 10.1016/j.clon.2007.01.436] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
|
15
|
Naderi A, Teschendorff A, Beigel J, Cariati M, Ellis I, Brenton J, Caldas C. Bex2 identifies a novel subtype of breast cancer associated with estrogen-response and NGF/NF-KB pathway. EJC Suppl 2006. [DOI: 10.1016/s1359-6349(06)80287-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|